Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.27
(-44.94%)
USD 0.27
(-44.94%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 18.42 Million USD | -17.82% |
| 2022 | 22.54 Million USD | 55.43% |
| 2021 | 14.5 Million USD | 5.91% |
| 2020 | 13.69 Million USD | 6.79% |
| 2019 | 12.82 Million USD | -2.11% |
| 2018 | 13.09 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.62 Million USD | 0.0% |
| 2024 Q1 | 4.62 Million USD | -11.22% |
| 2023 Q4 | 5.2 Million USD | 0.0% |
| 2023 Q1 | 4.12 Million USD | -72.61% |
| 2023 FY | 18.52 Million USD | -17.82% |
| 2023 Q3 | 5.2 Million USD | -34.95% |
| 2023 Q2 | 8 Million USD | 93.85% |
| 2022 Q2 | 12.22 Million USD | 107.9% |
| 2022 FY | 22.54 Million USD | 55.43% |
| 2022 Q1 | 5.87 Million USD | 76.52% |
| 2022 Q4 | 15.07 Million USD | 98.49% |
| 2022 Q3 | 7.59 Million USD | -37.87% |
| 2021 Q4 | 3.33 Million USD | 2.29% |
| 2021 Q3 | 3.25 Million USD | -2.9% |
| 2021 Q2 | 3.35 Million USD | 0.0% |
| 2021 Q1 | 3.35 Million USD | -1.3% |
| 2021 FY | 14.5 Million USD | 5.91% |
| 2020 Q2 | 3.18 Million USD | 0.0% |
| 2020 FY | 13.69 Million USD | 6.79% |
| 2020 Q4 | 3.39 Million USD | -0.0% |
| 2020 Q3 | 3.39 Million USD | 6.57% |
| 2020 Q1 | 3.18 Million USD | -2.57% |
| 2019 Q1 | 3.09 Million USD | 0.0% |
| 2019 Q4 | 3.27 Million USD | 0.0% |
| 2019 Q3 | 3.27 Million USD | 5.65% |
| 2019 Q2 | 3.09 Million USD | -0.0% |
| 2019 FY | 12.82 Million USD | -2.11% |
| 2018 FY | 13.09 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 82.334% |
| AngioDynamics, Inc. | 252.41 Million USD | 92.702% |
| AtriCure, Inc. | 327.05 Million USD | 94.368% |
| Avinger, Inc. | 18.63 Million USD | 1.169% |
| Azenta, Inc. | 336.26 Million USD | 94.522% |
| BioLife Solutions, Inc. | 117.57 Million USD | 84.334% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 98.991% |
| Daxor Corporation | 1.28 Million USD | -1338.489% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 23.856% |
| Femasys Inc. | 15.2 Million USD | -21.182% |
| GlucoTrack, Inc. | 7.1 Million USD | -159.291% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 68.556% |
| Hologic, Inc. | 1.34 Billion USD | 98.631% |
| ICU Medical, Inc. | 717.04 Million USD | 97.431% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.378% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 29.446% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 79.61% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 15536.368% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 15536.368% |
| Masimo Corporation | 867 Million USD | 97.875% |
| Microbot Medical Inc. | 9.85 Million USD | -86.911% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 95.995% |
| Nephros, Inc. | 9.78 Million USD | -88.267% |
| NovoCure Limited | 613.92 Million USD | 97.0% |
| NEXGEL, Inc. | 4.09 Million USD | -349.709% |
| NEXGEL, Inc. | 4.09 Million USD | -349.709% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 81.984% |
| OraSure Technologies, Inc. | 125.34 Million USD | 85.304% |
| Pro-Dex, Inc. | 7.37 Million USD | -149.662% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 57.727% |
| Predictive Oncology Inc. | 15.22 Million USD | -20.95% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -116.144% |
| QuidelOrtho Corporation | 1.35 Billion USD | 98.641% |
| Repligen Corporation | 261.12 Million USD | 92.946% |
| Sanara MedTech Inc. | 61.12 Million USD | 69.866% |
| STAAR Surgical Company | 224.55 Million USD | 91.797% |
| Sharps Technology, Inc. | 10.12 Million USD | -81.897% |
| Utah Medical Products, Inc. | 13.26 Million USD | -38.904% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 98.973% |
| Jin Medical International Ltd. | 3.91 Million USD | -370.191% |